ArticleInternational journal of hematology2013

Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.

Shingen Nakamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.